JPA Health is a public relations, marketing, and patient advocacy firm, providing pre- and post-approval medical communications services for large pharma and small to mid-size biotech organizations. Additionally, the Company provides medical communications services for the federal government and for NFPs (not-for-profits). JPA has approximately 80 employees. JPA’s health care focus, high quality work product, professional attitude, and strategic client engagement differentiate the Company from the broader competitive landscape of public relations firms.
Location: United States, District of Columbia, Washington
Investors 1
Date | Name | Website |
- | Great Poin... | gppfunds.c... |
Mentions in press and media 10
Date | Title | Description | Source |
01.11.2023 | New 'One World, One Health' Report Shows Critical Need for C... | JPA Health Unveils Connectability Score to Measure Relationships Between Key Audiences WASHINGTON, ... | en.prnasia... |
04.05.2022 | Great Point Partners Invests in JPA Health, Leading Marketin... | GREENWICH, Conn. and WASHINGTON (PRWEB) May 04, 2022 Today Great Point Partners (“GPP”), a Greenwic... | prweb.com/... |
03.11.2021 | Antios Therapeutics Raises $75 Million in a Series B-1 Fundi... | Antios Therapeutics, Inc. (“Antios”), a clinical-stage biopharmaceutical company developing innovati... | lumiravent... |
12.10.2021 | eXciteOSA® Daytime Sleep Apnea Therapy Device Surpasses 50,0... | Driving comfort and relief for patients with snoring and mild obstructive sleep apnea BOSTON and LO... | venturebea... |
27.07.2021 | Signifier Medical Technologies Raises $35M in Series D Fundi... | All the sessions from Transform 2021 are available on-demand now. Watch now. BOSTON & LONDON–(B... | venturebea... |
27.07.2021 | Signifier Medical Technologies Raises $35M in Series D Fundi... | BOSTON & LONDON–(BUSINESS WIRE)–July 27, 2021– Signifier Medical Technologies Ltd, a pioneer in... | venturebea... |
12.04.2021 | Xilio Therapeutics Strengthens Management Team with R&D ... | WALTHAM, Mass.--(BUSINESS WIRE)-- Xilio Therapeutics, a biotechnology company developing potent, tum... | svhealthin... |
24.02.2021 | Xilio Therapeutics Raises $95 Million in Series C Financing ... | February 24, 2021 06:00 AM Eastern Standard Time WALTHAM, Mass.--(BUSINESS WIRE)--Xilio Therapeutic... | svhealthin... |
- | JPA Health Recognized by PRWeek as 2021 Outstanding Small Ag... | WASHINGTON--(BUSINESS WIRE)--Mar 19, 2021-- JPA Health, a full-service agency specializing in publi... | oaoa.com/n... |
- | Xilio Therapeutics Raises $95 Million in Series C Financing ... | WALTHAM, Mass.--(BUSINESS WIRE)--Feb 24, 2021-- Xilio Therapeutics, a biotechnology company develop... | oaoa.com/n... |